Glaxosmithkline Plc ADR (GSK)

$45.47 0. (0.00%)

19:00 EST GSK Stock Quote Delayed 30 Minutes

7 Stocks to Buy if Covid-19 Becomes Endemic

By Josh Enomoto, InvestorPlace Contributor Dec 20, 2021

Watching the developments of the Covid-19 crisis, it could become endemic. Here’s what that means for certain stocks to buy.

VIR Stock Pops Amid Renewed Omicron Variant Concerns. Here’s Why.

The 7 Best Stocks to Buy for September

7 High-Yield Dividend Stocks to Get You Through Market Volatility

Volume:

Previous Close -

Market Cap 244.86B

PE Ratio -

EPS -

Volume (Avg. Vol.)

Day's Range -

52-Week Range $33.53 - $45.44

Dividend & Yield $2.14 (4.71%)

GSK Stock Predictions, Articles, and Glaxosmithkline Plc ADR News

From InvestorPlace
From the Web

ALEC Stock: 12 Things to Know About Alector as GSK News Sends It Rocketing Higher

By William White, InvestorPlace Writer Jul 2, 2021

Alector (ALEC) stock is rocketing higher on Friday after the biotechnology company announced a partnership with GlaxoSmithKline (GSK).

The 7 Best ESG Stocks to Buy for the Biggest (Socially Responsible) Gains

By Josh Enomoto, InvestorPlace Contributor Jun 29, 2021

While sustainable initiatives sound like a strategy for non-profit organizations, shifting demographics bode well for ESG stocks.

7 Pharmaceutical Stocks With Dividends in Hand

By Thomas Niel Apr 28, 2021

So, which pharmaceutical stocks should be on your radar, if dividends are a top priority? Consider these seven compelling opportunities.

7 Cheap Stocks That Won’t Be on Discount for Long

By Faizan Farooque Apr 6, 2021

Cheap, solid stocks may seem like a mirage considering the equity bull run, but several excellent investments are trading at a discount.

7 High-Yield Dividend Stocks With Enough Earnings to Cover the Dividends

By Mark R. Hake, CFA Mar 29, 2021

These 7 high-yield dividend stocks have yields above 5% and their payout ratios broadly look strong enough to support those dividends.

VIR Stock: Why Vir Biotechnology Is Plunging Today

By Chris MacDonald, InvestorPlace Contributor Mar 3, 2021

VIR stock is plunging on some pretty unfavorable news about a trial being suspended for the company's prospective Covid-19 vaccine.

7 Stocks to Sell for March

By Louis Navellier and the InvestorPlace Research Staff Feb 26, 2021

The market is starting to get volatile again and sector rotation is underway. Clear the decks by dumping these stocks to sell for March.

10 Dividend Stocks Increasing Their Payouts

By Will Ashworth, InvestorPlace Contributor Feb 19, 2021

When it comes to investing in dividend stocks, companies that significantly increase their payouts are more attractive than those with higher yields.

The Best 4 Pharmaceutical Stocks to Buy in Any Climate

By Joel Baglole Jan 22, 2021

Pharmaceutical stocks, such as Moderna and Novavaxsaw their share prices more than double in the last year. However, not all pharmaceutical stocks have their wagons hitched to solving the Covid-19 pandemic. There are many pharmaceutical stocks that are great long-term investments and would be good additions to a portfolio in any environment. Here we look at four such pharmaceutical stocks.

8 Dental Stocks If You Want to Clean Up

By Josh Enomoto, InvestorPlace Contributor Dec 31, 2020

As the Covid-19 pandemic worsens, the case for dental stocks to buy might not seem too bright. However, this sector is a very broad one, with upside opportunities available right now.

The 7 Best Coronavirus Vaccine Stocks Still In The Race For A Cure

By Tezcan Gecgil, InvestorPlace Contributor Dec 8, 2020

Buying strong vaccine stocks at the forefront of the scientific race to treat Covid-19 will help any long-term portfolio in 2021.

GlaxoSmithKline and Sanofi Stock Rally on EU Vaccine Deal

By Sarah Smith, Editor, Today's Market Sep 18, 2020

GlaxoSmithKline and Sanofi stock are rallying in early trading on Friday thanks to news they would supply the EU 300 million vaccine doses.

7 Coronavirus Vaccine Stocks to Watch as Approval Nears

By Thomas Niel Sep 14, 2020

Whether or not we get an 'October Surprise' from President Donald Trump, these coronavirus vaccine stocks look hot now. AstraZeneca (NYSE:AZN) CureVac (NASDAQ:CVAC) GlaxoSmithKline (NYSE:GSK) Inovio (NASDAQ:INO) Johnson & Johnson (NYSE:JNJ) Moderna (NASDAQ:MRNA) Novavax (NASDAQ:NVAX)